Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15471 | 28892095 | Lab Invest | Cholecystectomy as a risk factor of metabolic syndrome: from epidemiologic clues to biochemical mechanisms. | 2017 | Details |
| A15475 | 28887301 | J Biol Chem | The phospholipase PNPLA7 functions as a lysophosphatidylcholine hydrolase and interacts with lipid droplets through its catalytic domain. | 2017 | Details |
| A15476 | 28886991 | J Diabetes Complications | Molecular mechanisms of nonalcoholic fatty liver disease: Potential role for 12-lipoxygenase. | 2017 | Details |
| A15478 | 28883965 | Trop Dis Travel Med Vaccines | Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era. | 2016 | Details |
| A15479 | 28883861 | Arch Med Sci | Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women. | 2017 | Details |
| A15480 | 28883393 | Nat Commun | Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function. | 2017 | Details |
| A15483 | 28880885 | PLoS One | Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children. | 2017 | Details |
| A15485 | 28880231 | Nutrients | The Impact of Sex and 25(OH)D Deficiency on Metabolic Function in Mice. | 2017 | Details |
| A15487 | 28878826 | Diabetol Metab Syndr | Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15489 | 28878197 | Nutrients | Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15490 | 28878132 | JCI Insight | Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. | 2017 | Details |
| A15496 | 28875689 | Minerva Gastroenterol Dietol | Liver fibrosis in the context of nonalcoholic steatohepatitis: the role of adipokines. | 2017 | Details |
| A15501 | 28874313 | Gastroenterol Hepatol | New therapeutic perspectives in non-alcoholic steatohepatitis. | 2017 | Details |
| A15507 | 28869588 | Lab Invest | Activation of pluripotent genes in hepatic progenitor cells in the transition of nonalcoholic steatohepatitis to pre-malignant lesions. | 2017 | Details |
| A15508 | 28869506 | Int J Mol Sci | Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases. | 2017 | Details |
| A15509 | 28868358 | AACE Clin Case Rep | GLYCOGENIC HEPATOPATHY: A COMPLICATION OF UNCONTROLLED DIABETES. | 2017 | Details |
| A15511 | 28868179 | World J Gastrointest Pathophysiol | Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients. | 2017 | Details |
| A15512 | 28868048 | Front Endocrinol (Lausanne) | Extracellular Vesicles from Adipose Tissue-A Potential Role in Obesity and Type 2 Diabetes? | 2017 | Details |
| A15513 | 28867301 | Cell Metab | Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. | 2017 | Details |
| A15524 | 28862329 | J Sci Food Agric | Virgin coconut oil reverses hepatic steatosis by restoring redox homeostasis and lipid metabolism in male Wistar rats. | 2017 | Details |
| A15528 | 28859855 | Gastroenterology | Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. | 2017 | Details |
| A15547 | 28848738 | Front Cardiovasc Med | Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. | 2017 | Details |
| A15567 | 28840697 | Zhongguo Zhong Yao Za Zhi | [Effect of Psoralea corylifolia in treating fatty liver disease in juvenal mouse by inhibiting hepatic NF-κB activation]. | 2017 | Details |
| A15569 | 28840257 | Diabetologia | Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. | 2017 | Details |
| A15573 | 28838784 | Clin Gastroenterol Hepatol | Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis. | 2017 | Details |
| A15577 | 28836404 | Cell J | Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats. | 2017 | Details |
| A15582 | 28831172 | Sci Rep | Pioglitazone Enhances Cytosolic Lipolysis, β-oxidation and Autophagy to Ameliorate Hepatic Steatosis. | 2017 | Details |
| A15583 | 28830448 | Lipids Health Dis | Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD). | 2017 | Details |
| A15585 | 28828531 | Abdom Radiol (NY) | Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors. | 2018 | Details |
| A15588 | 28825992 | J Nutr Biochem | Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice. | 2017 | Details |
| A15600 | 28820447 | Int J Mol Sci | Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats. | 2017 | Details |
| A15601 | 28820393 | J Physiol Pharmacol | Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease. | 2017 | Details |
| A15607 | 28814531 | J Nutr | Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation. | 2017 | Details |
| A15608 | 28812576 | Eur J Clin Nutr | Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study. | 2017 | Details |
| A15610 | 28811690 | Indian J Clin Biochem | Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation. | 2016 | Details |
| A15611 | 28811651 | Int J Obes (Lond) | iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. | 2017 | Details |
| A15617 | 28805745 | Children (Basel) | Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics. | 2017 | Details |
| A15618 | 28805669 | Nutrients | Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. | 2017 | Details |
| A15620 | 28804947 | J Clin Periodontol | Periodontitis and Non-alcoholic Fatty Liver Disease, a population-based cohort investigation in the Study of Health in Pomerania. | 2017 | Details |
| A15625 | 28802640 | Clin Chim Acta | Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins. | 2017 | Details |
| A15628 | 28802074 | Hepatology | Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. | 2017 | Details |
| A15633 | 28797988 | Turk J Gastroenterol | Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease. | 2017 | Details |
| A15635 | 28797077 | PLoS One | Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1. | 2017 | Details |
| A15636 | 28796993 | Digestion | Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model. | 2017 | Details |
| A15643 | 28791501 | J Gastroenterol | Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease. | 2017 | Details |
| A15656 | 28777914 | Can J Physiol Pharmacol | Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption. | 2017 | Details |
| A15658 | 28777879 | Hepatology | Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. | 2017 | Details |
| A15681 | 28767077 | Children (Basel) | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15682 | 28763870 | Zhonghua Gan Zang Bing Za Zhi | [Effect of liraglutide in treatment of non-alcoholic fatty liver disease: mechanism of action and research advances]. | 2017 | Details |
| A15683 | 28763845 | Zhonghua Gan Zang Bing Za Zhi | [Sivelestat alleviates nonalcoholic steatohepatitis in mice through inhibiting activation of Kupffer cells]. | 2017 | Details |
| A15685 | 28760353 | Clin Res Hepatol Gastroenterol | Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. | 2017 | Details |
| A15686 | 28759939 | Horm Metab Res | Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial. | 2017 | Details |
| A15690 | 28759573 | PLoS One | Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis. | 2017 | Details |
| A15694 | 28758096 | Ann Transl Med | Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. | 2017 | Details |
| A15698 | 28753963 | Nutrients | The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats. | 2017 | Details |
| A15699 | 28752920 | Liver Transpl | Outcome of liver transplantation in patients with prior bariatric surgery. | 2017 | Details |
| A15701 | 28752050 | Mol Metab | Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. | 2017 | Details |
| A15705 | 28751149 | Diabetes Metab Syndr | The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2017 | Details |
| A15708 | 28750643 | Lipids Health Dis | Isolated hypercholesterolemia leads to steatosis in the liver without affecting the pancreas. | 2017 | Details |
| A15714 | 28748119 | J Adv Res | Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. | 2016 | Details |
| A15723 | 30603331 | Diabetol Int | Immune regulation of glucose and lipid metabolism. | 2017 | Details |
| A15728 | 28741239 | Obes Surg | Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features. | 2018 | Details |
| A15732 | 28739572 | Mol Pharmacol | Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X Receptor. | 2017 | Details |
| A15735 | 28737569 | J Pediatr Gastroenterol Nutr | Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15746 | 28730823 | Physiol Res | Pathophysiological analysis of the progression of hepatic lesions in STAM mice. | 2017 | Details |
| A15764 | 28722242 | Diabetes Obes Metab | Therapeutic application of GPR119 ligands in metabolic disorders. | 2017 | Details |
| A15767 | 28720429 | Pharmacol Ther | Stable isotope-based flux studies in nonalcoholic fatty liver disease. | 2017 | Details |
| A15770 | 28718838 | Nutrients | Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats. | 2017 | Details |
| A15772 | 28718215 | Hepatology | USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity. | 2017 | Details |
| A15776 | 28714900 | Int J Mol Sci | A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15777 | 28714405 | Curr Pharm Des | Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter. | 2017 | Details |
| A15781 | 28711683 | Biochimie | Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice. | 2017 | Details |
| A15784 | 28710554 | Obes Surg | Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A15794 | 28706613 | Avicenna J Med Biotechnol | Major Components of Metabolic Parameters and Nutritional Intakes in Different Genotypes of Adiponectin +276 G>T Gene Polymorphism in Non-Diabetes and Non-Alcoholic Iranian Fatty Liver Patients. | 2020 | Details |
| A15798 | 28705172 | BMC Endocr Disord | Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss. | 2017 | Details |
| A15806 | 28699662 | J Gastroenterol Hepatol | Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice. | 2018 | Details |
| A15807 | 28699612 | Indian Pediatr | Relationship Between Immune Parameters and Non-alcoholic Fatty Liver Disease in Obese Children. | 2017 | Details |
| A15808 | 28699503 | Curr Med Chem | Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach. | 2017 | Details |
| A15811 | 28698350 | BMJ Open | Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. | 2017 | Details |
| A15812 | 28696785 | Arch Physiol Biochem | Exendin-4, a glucagon-like peptide-1 receptor agonist downregulates hepatic receptor for advanced glycation end products in non-alcoholic steatohepatitis rat model. | 2017 | Details |
| A15820 | 28694246 | Eur J Endocrinol | MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease. | 2017 | Details |
| A15834 | 28689596 | Clin Liver Dis | Extrahepatic Manifestations of Hepatitis C Virus After Liver Transplantation. | 2017 | Details |
| A15836 | 28689378 | Postepy Biochem | The roles of annexins in vascular endothelium dysfunction accompanying diabetes mellitus type 2. | 2017 | Details |
| A15837 | 28688543 | Eur J Intern Med | Liver steatosis: The new epidemic of the Third Millennium. Benign liver state or silent killer? | 2017 | Details |
| A15845 | 28685623 | Expert Opin Pharmacother | Cardiovascular disease prevention strategies for type 2 diabetes mellitus. | 2017 | Details |
| A15849 | 28683283 | Cell Metab | Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. | 2017 | Details |
| A15850 | 28681988 | Diabetes Obes Metab | Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial. | 2017 | Details |
| A15852 | 28680417 | Front Endocrinol (Lausanne) | Alternative RNA Splicing in the Pathogenesis of Liver Disease. | 2017 | Details |
| A15856 | 28679028 | Liver Int | Hepatic iron is the major determinant of serum ferritin in NAFLD patients. | 2017 | Details |
| A15857 | 28678821 | PLoS One | A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice. | 2017 | Details |
| A15859 | 28678199 | Int J Mol Sci | The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. | 2017 | Details |
| A15872 | 28676026 | Curr Vasc Pharmacol | A Critical Approach of Guideline Therapeutic Recommendations for NAFLD. | 2018 | Details |
| A15877 | 28676018 | Curr Vasc Pharmacol | Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? | 2018 | Details |
| A15882 | 28673684 | Toxicol Appl Pharmacol | The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. | 2017 | Details |
| A15886 | 28670854 | J Gastroenterol Hepatol | Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ. | 2018 | Details |
| A15890 | 28669328 | Curr Vasc Pharmacol | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | 2018 | Details |
| A15892 | 28667519 | Sci China Life Sci | Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1. | 2017 | Details |
| A15894 | 28666456 | Lipids Health Dis | Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. | 2017 | Details |
| A15901 | 28660493 | Diabetologia | Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study. | 2017 | Details |
| A15903 | 28660148 | J Clin Transl Hepatol | Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. | 2017 | Details |